The Utility of Rapid Nucleic Acid Amplification Testing to Triage Symptomatic Patients and to Screen Asymptomatic Preprocedure Patients for SARS-CoV-2-Reference-Cited by-同舟云学术

The Utility of Rapid Nucleic Acid Amplification Testing to Triage Symptomatic Patients and to Screen Asymptomatic Preprocedure Patients for SARS-CoV-2

Published:2020-12-17 Issue:1 Volume:8 Page:
ISSN:2328-8957
Container-title:Open Forum Infectious Diseases
language:en
Short-container-title:

Author:

Tworek Joseph A¹,Khan Faisal²,Sekedat Matthew D²,Scheidel Caleb³,Malani Anurag N⁴⁵

Affiliation:

1. Department of Pathology, St Joseph Mercy Hospital, Ann Arbor, Michigan, USA

2. Warde Medical Laboratory, Ann Arbor, Michigan, USA

3. Methods Consultants of Ann Arbor, Ypsilanti, Michigan, USA

4. Division of Infectious Diseases, Department of Internal Medicine, St Joseph Mercy Hospital, Ann Arbor, Michigan, USA

5. Department of Infection Prevention and Control, St Joseph Mercy Hospital, Ann Arbor, Michigan, USA

Abstract

Abstract We investigate the utility of the ID Now when compared to RT-PCR to triage patients suspected of having COVID-19 presenting to emergency rooms (ERs) and to screen asymptomatic patients presenting for pre-procedural testing. We find it useful when prevalence of COVID-19 is high in symptomatic patents and potentially useful in asymptomatic patients who are likely to be retested if symptoms emerge.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Oncology

Link

http://academic.oup.com/ofid/advance-article-pdf/doi/10.1093/ofid/ofaa607/34931131/ofaa607.pdf

Reference6 articles.

1. Performance of Abbott ID Now COVID-19 rapid nucleic acid amplification test using nasopharyngeal swabs transported in viral transport media and dry nasal swabs in a New York City academic institution;Basu;J Clin Microbiol,2020

2. Clinical evaluation of three sample-to-answer platforms for the detection of SARS-CoV-2;Zhen;J Clin Microbiol,2020

3. Evaluation of the COVID19 ID NOW EUA assay;Mitchell;J Clin Virol,2020

4. Comparison of Abbott ID Now and Abbott m2000 methods for the detection of SARS-CoV-2 from nasopharyngeal and nasal swabs from symptomatic patients;Harrington;J Clin Microbiol,2020

5. Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche Cobas for the rapid detection of SARS-CoV-2;Smithgall;J Clin Virol,2020

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The diagnostic accuracy of the ID NOW COVID-19 point of care test in acute hospital admissions;Journal of Clinical Virology;2024-02

2. Point-of-Care Testing for SARS-CoV-2: A Prospective Study in a Primary Health Centre;Diagnostics;2023-05-28

3. Pre-Endoscopy real-time PCR testing for SARS-CoV2 does not reduce health care workers infection and is associated with a higher reduction of endoscopic activity in an outpatient setting;Acta Gastro Enterologica Belgica;2022-12

4. Point of care molecular and antigen detection tests for COVID-19: current status and future prospects;Expert Review of Molecular Diagnostics;2022-08-03

5. Diagnostic accuracy of the Abbott ID NOW SARS-CoV-2 rapid test for the triage of acute medical admissions;Journal of Hospital Infection;2022-05